Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I

Speciality: Oncology


Speaker:

Dr. Todd Bauer | Senior Investigator, Sarah Cannon Research Institute, Medical Oncologist & Partner, Tennessee Oncology, PLLC Nashville

Dr. Ullas Batra | Senior Consultant and Unit Head, Rajiv Ganghi Cancer Institute and Research Center

Description:

A warm welcome to all the medical professionals in this interesting learning session on understanding the best treatment approaches of ALK positive lung cancer.

In this webinar, a panel discussion would take place involving Dr. Todd Bauer as the primary speaker and Dr. Ullas Batra as a moderator who will share the important facts associated with treatment approaches for management of ALK positive lung cancer.

Dr. Todd Bauer has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, a discussion on all possible treatment approaches and their pros, cons are discussed.

ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.

Therefore,  you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study sets benchmark for treatment of advanced cervical cancer

2.

"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.

3.

Children with rare gliomas have new hope thanks to clinical trial results.

4.

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

5.

For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot